Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma

J.J. Castillo, T. Guerrero-Garcia, F. Baldini, E. Tchernonog, G. Cartron, S. Ninkovic, K. Cwynarski, D. Dierickx, T. Tousseyn, F. Lansigan, Y. Linnik, R. Mogollon, J.-T. Navarro, A.J. Olszewski, J.L. Reagan, P. Fedele, M. Gilbertson, G. Grigoriadis, M. Bibas

Research output: Contribution to journalArticle

Original languageEnglish
JournalBritish Journal of Haematology
DOIs
Publication statusPublished - 2018

Cite this